Lymphohistiocytoid mesothelioma is an extremely rare cell subtype of mesothelioma, accounting for less than 1% of diagnosed asbestos cancer cases. Lymphohistiocytoid mesothelioma is a type of sarcomatoid mesothelioma, which is aggressive and difficult to treat. It is easy to misdiagnose this cancer as the more common lymphoma.
If you or a loved one have been diagnosed with mesothelioma, asbestos-related lung cancer, or asbestosis, you may be eligible for a large amount of compensation. Currently, there is over $30 billion in asbestos trust funds. FComplete nuestro formulario para obtener un Paquete de Compensación Financiera gratuito. Aprenderá sobre los abogados con experiencia en mesotelioma en su área, cómo recibir su pago en 90 días, cómo presentar una reclamación a los fondos fiduciarios de asbesto y más.


Paquete de compensación financiera GRATUITO
- Información sobre despachos de abogados que recuperarán su INDEMNIZACIÓN MÁS ALTA
- Aprenda cómo cobrar en 90 días
- Solicite su parte de $30 mil millones en fondos fiduciarios
What Is Lymphohistiocytoid Mesothelioma?
Lymphohistiocytoid mesothelioma is a rare, aggressive, sarcomatoid type of mesothelioma. These tumors often contain inflammatory immune cells, white blood cells, and histiocytes. They sometimes also have some epithelioid cells.
About Mesothelioma Cell Types
Mesothelioma is often categorized by the location of tumors: pleural, peritoneal, and pericardial. It can also be categorized by cell type:
- Epithelioid – Cells that line the surfaces of organs and a less aggressive type of mesothelioma
- Sarcomatoid – Fibrous cancer cells of connective tissue and a more aggressive type of mesothelioma
- Biphasic – A mixture of epithelioid and sarcomatoid cells
Most of the few cases of lymphohistiocytoid mesothelioma diagnoses were sarcomatoid. More recent studies indicate that this type of mesothelioma might actually behave more like the epithelial type.
Sarcomatoid mesothelioma cells spread more readily than epithelial cells. In general, sarcomatoid mesotheliomas are more aggressive and have a poorer prognosis.
Diagnosing Lymphohistiocytoid Mesothelioma
With so few cases, there is not much information on lymphohistiocytoid mesothelioma. Because it is so rare, few patients have been studied. Instead, experts rely on the tumor characteristics to help provide a correct diagnosis.
Lymphohistiocytoid tumors, as mentioned earlier, typically have a large number of immune cells. This makes diagnóstico difficult as it mimics other more common diseases.
The National Institutes of Health (NIH) states that this form of mesothelioma has been misdiagnosed as ganglioneuroma, malignant lymphoma, and inflammatory pseudotumor.
To differentiate the tumors, doctors take samples during a biopsy so that pathologists can identify the cells. When studying the tumor sample, physicians look for a histological type that shows histiocytoid cells shaped like a spindle.
Most cells are large and polygonal-shaped as well. White blood cells are generally found mixed into the cells. These characteristics and fluid buildup in the lungs and other related symptoms help doctors confirm the diagnosis.
Full immunohistochemical staining of the cells is required before doctors can confirm a diagnosis. This process helps differentiate other cells that closely resemble each other.
Misdiagnosis of Lymphohistiocytoid Mesothelioma
Any rare cancer is likely to be misdiagnosed as something more common. Lymphohistiocytoid mesothelioma can be easily confused with lymphoma. Lymphoma is a cancer of lymphocytes, cells in the immune system.
Other cancers or tumors that lymphohistiocytoid might be misdiagnosed as include:
- Thymoma
- Lymphoepithelial carcinoma
- Ganglioneuroma
- Inflammatory pseudotumors
- Sarcomatoid lung cancer
Lymphohistiocytoid Mesothelioma Symptoms
Lymphohistiocytoid mesothelioma symptoms closely resemble symptoms of other cell types of pleural mesothelioma. Early warning signs of pleural mesothelioma include:
- Dolores en el pecho
- Tos
- Dificultad para respirar
- sibilancias
- Dificultad para respirar
As mesothelioma progresses, these symptoms get worse, and new symptoms often arise:
- Fatiga
- Pérdida de peso
- Small bumps and lumps under the skin, around the chest area
- Sudores nocturnos
- Fiebre
- Lower back pain
Treating Lymphohistiocytoid Mesothelioma
With such limited information on lymphohistiocytoid mesothelioma, physicians usually rely on standard forms of mesothelioma treatment, incluido cirugía, quimioterapia, radiation therapy, and immunotherapy.
Most patients benefit from multimodal therapy, a combination of two or more treatments. Surgery is the best option for extending life expectancy, but not all patients are good candidates for it, especially those with sarcomatoid mesothelioma.
Combinations of chemotherapy, immunotherapy, radiation therapy, and emerging treatments can help relieve symptoms. They may also extend a patient’s life expectancy.
Lymphohistiocytoid Mesothelioma Prognosis
According to the American Journal of Clinical Pathology (AJCP), in the 1980s, early cases of lymphohistiocytic mesothelioma indicated that the prognosis was not favorable after several patients died within five months of treatment.
However, later studies conducted in the 2000s showed that with the right treatment, the survival rate for those with lymphohistiocytoid mesothelioma can be extended up to two years.
As with all cases of mesothelioma, however, it’s important to remember the survival rates vary significantly. Whereas one person may only survive five months, another patient may go on to live years with the right treatment, diet plan, exercise, and other healthy lifestyle choices.
Another study indicated that a few patients with lymphohistiocytoid mesothelioma have lived more than five years after diagnosis.
If you have been diagnosed with any type of mesothelioma, talk to a lawyer about options. You can probably hold companies accountable for past asbestos exposure.
Additional Resources and Helpful Information
No olvides rellenar nuestro formulario para obtener nuestro regalo gratis. Paquete de compensación financiera, lleno de información sobre los abogados con experiencia en asbesto y mesotelioma en su área. Keep in mind that if you’ve been diagnosed with mesothelioma, asbestos-related lung cancer, or asbestosis, you may be eligible for considerable compensation to help cover expenses for medical costs, as well as compensation for pain, suffering, and much more. For additional assistance, contact us at 800-793-4540.

Pablo Danziger
Revisor y editorPaul Danziger creció en Houston, Texas, y se licenció en Derecho en la Facultad de Derecho de la Universidad Northwestern en Chicago. Durante más de 25 años, se ha dedicado a representar a víctimas de mesotelioma y a otras personas afectadas por la exposición al asbesto. Paul y su bufete han representado a miles de personas diagnosticadas con mesotelioma, asbestosis y cáncer de pulmón, obteniendo indemnizaciones significativas para los clientes lesionados. Cada cliente es fundamental para Paul y atenderá todas las llamadas de quienes deseen hablar con él. Paul y su bufete se encargan de casos de mesotelioma en todo Estados Unidos.
Conéctese con el abogado especializado en mesotelioma Paul Danziger
Referencias
- Khalidi, H.S., Madeiros, L.J., and Battifora, H. (2000, May). Lymphohistiocytoid Mesothelioma. An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma. Am. J. Clin. Pathol. 113(5), 649-54.
Recuperado de: http://www.ncbi.nlm.nih.gov/pubmed/10800396 - E-Immunohistochemistry.info. (2007, May 31). Lymphohistiocydoid Malignant Mesothelioma.
Recuperado de: http://e-immunohistochemistry.info/web/Lymphohistiocytoid_malignant_mesothelioma.htm - Galateau-Salle, F., Attanoos, R., Gibbs, A.R., Burke, L., Astoul, P., Rolland, P., Ilg, A., Pairon, J.C., Brochard, P., Begueret, H., Vignaud, J.M., Kerr, K., Launoy, G., Imbernon, E., and Goldberg, M. (2007, May). Am. J. Surg. Pathol. 31(5), 711-16.
Recuperado de: https://journals.lww.com/ajsp/Abstract/2007/05000/Lymphohistiocytoid_Variant_of_Malignant.8.aspx - Matsubara, T., Toyokawa, G., Yamada, Y., Nabeshima, K., Haratake, N., Kozuma, Y., Akamine, T., Takamori, S., Shoji, F., Okamoto, T., and Maehara, Y. (2017, December). A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis. Anticancer Resarch. 37(12), 6937-41.
Recuperado de: https://ar.iiarjournals.org/content/37/12/6937.full - Yao, D.X., Shia, J., Erlandson, R.A., and Klimstra, D.S. (2004). Lymphohistiocytoid Mesothelioma: A Clinical, Immunohistochemical and Ultrastructural Study of Four Cases and Literature Review. Ulstrastruct. Pathol. 28(4), 213-28.
Recuperado de: https://pubmed.ncbi.nlm.nih.gov/15693633/